Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Inflazyme announces phase Ia and Ib results with IPL-512602

Nov. 12, 2002

Ono scientists design novel chemokine antagonists for asthma, arthritis, etc.

Nov. 12, 2002

Orphan drug status granted for P-113D

Nov. 8, 2002

Semisynthetic ciclosporin derivatives for use in respiratory disorders prepared at Enanta

Nov. 8, 2002

Schering-Plough obtains marketing rights to Foradil Aerolizer from Novartis

Nov. 7, 2002

GSK patent covers new beta2-adrenoceptor agonists with utility in respiratory disorders

Nov. 7, 2002

Pascolizumab characterized preclinically prior to clinical studies

Oct. 30, 2002

ALK-Abello and Schering-Plough to develop tablet-based allergy immunotherapy

Oct. 28, 2002

Genaera provides Lomucin update in cystic fibrosis and asthma

Oct. 25, 2002

Novel gene therapy approach to the treatment of asthma based on IgE-binding protein

Oct. 24, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...